Galunisertib (LY2157299) is a TGF-beta receptor type I (TGF-betaRI) inhibitor (IC50=56 nM) that is selective. Galunisertib has antitumor activity and can be used in combination with PD-1 inhibitors.
Molecular Weight:
369.42
Purity:
97.09%
CAS Number:
[700874-72-2]
Formula:
C22H19N5O
Target:
TGF-beta/Smad
T2510
* VAT and and shipping costs not included. Errors and price changes excepted